- Home
- AORT vs NFJ Comparison
AORT vs NFJ Comparison
Compare AORT & NFJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AORT
- NFJ
- Stock Information
- Founded
- AORT 1984
- NFJ 2005
- Country
- AORT United States
- NFJ United States
- Employees
- AORT N/A
- NFJ N/A
- Industry
- AORT Medical/Dental Instruments
- NFJ Finance: Consumer Services
- Sector
- AORT Health Care
- NFJ Finance
- Exchange
- AORT Nasdaq
- NFJ Nasdaq
- Market Cap
- AORT 1.0B
- NFJ 1.1B
- IPO Year
- AORT 1993
- NFJ N/A
- Fundamental
- Price
- AORT $30.26
- NFJ $12.03
- Analyst Decision
- AORT Strong Buy
- NFJ
- Analyst Count
- AORT 6
- NFJ 0
- Target Price
- AORT $32.00
- NFJ N/A
- AVG Volume (30 Days)
- AORT 305.7K
- NFJ 223.5K
- Earning Date
- AORT 08-07-2025
- NFJ 01-01-0001
- Dividend Yield
- AORT N/A
- NFJ 9.01%
- EPS Growth
- AORT N/A
- NFJ N/A
- EPS
- AORT N/A
- NFJ N/A
- Revenue
- AORT $390,084,000.00
- NFJ N/A
- Revenue This Year
- AORT $12.18
- NFJ N/A
- Revenue Next Year
- AORT $10.39
- NFJ N/A
- P/E Ratio
- AORT N/A
- NFJ N/A
- Revenue Growth
- AORT 5.94
- NFJ N/A
- 52 Week Low
- AORT $21.97
- NFJ $10.45
- 52 Week High
- AORT $32.33
- NFJ $12.86
- Technical
- Relative Strength Index (RSI)
- AORT 65.93
- NFJ 49.21
- Support Level
- AORT $28.14
- NFJ $12.00
- Resistance Level
- AORT $29.59
- NFJ $12.19
- Average True Range (ATR)
- AORT 0.67
- NFJ 0.13
- MACD
- AORT -0.04
- NFJ -0.04
- Stochastic Oscillator
- AORT 88.33
- NFJ 11.76
About AORT Artivion Inc.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others.
About NFJ Virtus Dividend Interest & Premium Strategy Fund of Beneficial Interest
Virtus Dividend, Interest & Premium Strategy Fund is a Massachusetts-based business trust. The primary investment objective of the company is to seek current income and gains, with a secondary objective of long-term capital appreciation. The fund pursues its investment objectives by investing in a diversified portfolio of dividend-paying common stocks and income-producing convertible securities.